Despite widespread application of nucleic acid diagnostics, cultures remain integral in modern laboratories. Because cultures detect a large number of organism types, it is unlikely that they will disappear from clinical practice in the near future. Their downside is slow turn-around time, impacted by time to growth and identification of that growth. The latter is expedited using a new proteomic technology, matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).
Despite widespread application of nucleic acid diagnostics, cultures remain integral in modern laboratories. Because cultures detect a large number of organism types, it is unlikely that they will disappear from clinical practice in the near future. Their downside is slow turn-around time, impacted by time to growth and identification of that growth. The latter is expedited using a new proteomic technology, matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).
Historically, identification of cultured bacteria and fungi has been a complex, algorithmic task. Textbooks, flowcharts, and tables have been used to interpret colony morphology as well as stains and biochemical tests performed on colonies. Phenotypic tests may be contingent on subsequent growth, prolonging time to identification. Manual biochemical tests (eg, coagulase, catalase) are rapid, but identify limited organism types (eg, Staphylococcus aureus). Biochemical test panels performed manually (eg, API strips, bioMérieux, Durham, North Carolina) or on automated instruments (eg, VITEK, bioMérieux; BD Phoenix Automated Microbiology System, BD, Franklin Lakes, New Jersey; MicroScan, Siemens Healthcare Diagnostics, Tarrytown, New York) identify more microorganisms, but have longer turn-around times and costly consumables, and often require knowledge of the organism type being tested (eg, gram-positive cocci). Finally, broad-range PCR followed by sequencing accurately identifies bacteria and fungi but has a long turn-around time, and is expensive and performed in select laboratories. With MALDI-TOF MS, colonies growing in culture are inexpensively and accurately identified in minutes, without a priori knowledge of microorganism type; users do not even need to know whether a bacterium or a yeast is being tested. The product of advances in mass spectrometry and bioinformatics, MALDI-TOF MS is revolutionizing bacterial and fungal identification in clinical microbiology [1] .
The concept of using mass spectrometry to identify bacteria (albeit not based on proteomics) was proposed in the 1970s [2] ; with the Nobel Prize-winning invention of MALDI-TOF MS in the 1980s [3, 4] , whole-organism proteomics became possible. It took until the 1990s for development of libraries of reference spectra and software for bacterial identification, and until the past few years for commercialization of the technology [1, 5] . MALDI-TOF MS, used for a few years in European clinical microbiology laboratories, and being rapidly adopted worldwide, is likely to antiquate most biochemical microbial identification in the near future.
The simplest MALDI-TOF MS applications test bacterial or yeast colonies without elaborate preparation and using minimal consumables, providing rapid and low-cost identification. Testing begins by "picking" an unknown colony from a culture plate to a "spot" on a MALDI-TOF MS target plate (Figure 1 ). The cells may be treated on the target plate (we use formic acid) and are ultimately overlain with 1-2 μL of matrix. Following a short drying period, the plate is placed in the ionization chamber of the mass spectrometer ( Figure 2) .
"MALDI" refers to the matrix, which assists in the desorption and ionization of microbial analytes through pulses of energy from an ultraviolet N 2 laser. The matrix (eg, α-cyano-4-hydroxycinnamic acid dissolved in 50% acetonitrile and 2.5% trifluoroacetic acid) isolates microbial molecules from each other; microbial and matrix molecules on the target plate are desorbed, with the majority of energy being absorbed by the matrix, converting it to an ionized state. Through random collision in the gas phase, charge is transferred from matrix to microbial molecules; analytes within the mass range specified are measured, the most abundant being ribosomal proteins. The cloud of ionized microbial proteins is funneled through a positively charged electrostatic field into a time of flight or "TOF" mass analyzer, a tube under vacuum. The ions travel toward an ion detector with small analytes traveling fastest, followed by progressively larger analytes. A mass spectrum is generated, representing the number of ions of a given mass impacting the ion detector over time.
Analytes are not individually characterized; instead, the generated mass spectrum provides a profile ("fingerprint") of the unknown microorganism. Generated mass spectra are unique to individual microorganism types, with peaks specific to genera, species, and even strains. The test isolate's mass spectrum is automatically compared to a database of reference Figure 1 . Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) workflow. A bacterial or fungal colony (typically single) is "picked" from a culture plate to a "spot" on a MALDI-TOF MS target plate (a reusable or disposable plate with a number of test spots) using a wooden or plastic stick, pipette tip, or loop. One or many isolates may be tested at one time. At our institution, cells are treated with formic acid on the target plate. The spot is then overlain with 1-2 μL of matrix. Following a short drying period, the plate is placed in the ionization chamber of the mass spectrometer for analysis (see Figure 2) . A mass spectrum is generated and automatically compared against a database of mass spectra by the software, resulting in identification of the organism (Candida parapsilosis in position A4 in the example). More complex preparatory protein extraction, commonly used in older studies, may be performed prior to target plate inoculation. Although this yields high-quality mass spectra [46] , it is technically cumbersome; direct on-plate testing using formic acid identifies a similar number of organisms [37] . Direct on-plate testing must be avoided with organisms hazardous to microbiology technologists (eg, Brucella species) [28] . Reproduced by permission of Mayo Foundation for Medical Education and Research. All rights reserved. spectra to determine the relatedness of the spectrum to spectra in the database; a list of most closely related organisms is generated, each with a numeric ranking (percentage or score) indicating the level of confidence in identification. Depending on how high the value is, the organism is identified at the family, genus, or species level. As with any identification system, well-curated spectral databases representing comprehensive collections of correctly named and clinically relevant bacteria and fungi are necessary. In the absence of mass spectral entries in a database, entries may be manually added (assuming availability of requisite isolates). The time from putting the target plate into the instrument to final result is fast; for example, the Bruker system produces results in ≤3 minutes per isolate. No mass spectrometry expertise is required, and the technology is "green" with reusable target plates available and few disposables.
Commercial MALDI-TOF MS systems are available from Bruker Daltonics Inc (Billerica, Massachusetts) and bioMérieux Inc. A system used primarily in France (Andromas, Paris, France), will not be further discussed. The Bruker Biotyper system is most well studied and includes a mass spectrometer, software, and library; over the past few years, improved software and progressively more comprehensive and better curated mass spectral libraries have been made available. AnagnosTec (Zossen, Germany) previously marketed a microbial database called SARAMIS used with Shimadzu's AXIMA Assurance mass spectrometer (Shimadzu, Columbia, Maryland), which was acquired by bioMérieux in 2010; with this acquisition, the system's name was changed to VITEK MS RUO. BioMérieux developed its own database/operating software/algorithms, referred to as VITEK MS (including a prerelease version of the VITEK MS v1.1 database [6] , the v1 system/v1.1 database [7] [8] [9] [10] , the v2.0 system/v2.0 database and algorithms, and VITEK MS Plus, which incorporates the VITEK MS v2.0 and SARAMIS v4.0 databases). Rapidly implemented progressive improvements in both systems are enhancing the clinical laboratory's ability to identify a range of organisms but render it challenging for those reading the literature to compare studies due to variable software, interpretive rules, databases, mass spectrometers, comparators, specimen preparations, organism sets (ie, enriched for unusual organisms, or not), and so forth. Current systems' databases are generally best for common aerobic gram-negative bacilli and gram-positive cocci, and may lack some esoteric organisms, such as certain anaerobes, fungi, and mycobacteria. Given changing nomenclature and ongoing description of new species and emerging microorganisms, regular and ongoing updates to databases are imperative to ensure clinical utility. Databases should include entries representing major phylogenetic lineages within each species. It is possible for users to add their own mass spectral entries to enhance existing databases or create their own database by including locally important strains or strains not well represented in commercial libraries.
The Bruker and bioMérieux MALDI-TOF MS systems differ in databases, algorithms used to identify organisms, and instrumentation. Numeric rankings are reported on different scales, and are not directly comparable. Bruker's Microflex LT mass spectrometer is a desktop instrument, whereas bioMérieux's is a larger, floor model. At this time, neither system is approved by the US Food and Drug Administration. Matrix-assisted laser desorption ionization-time of flight mass spectrometer. The target plate is placed into the ionization chamber of the mass spectrometer. Spots to be analyzed are shot by an ultraviolet N 2 laser desorbing microbial and matrix molecules from the target plate. The majority of energy is absorbed by the matrix, converting it to an ionized state. Through random collision in the gas phase, charge is transferred from matrix to microbial molecules. The cloud of ionized molecules is funneled through a positively charged electrostatic field into the time of flight mass analyzer, a tube under vacuum. The ions travel toward an ion detector with small analytes traveling fastest, followed by progressively larger analytes. As ions emerge from the mass analyzer, they collide with an ion detector generating a mass spectrum representing the number of ions hitting the detector over time. Although separation is by massto-charge ratio, because the charge is typically single for the described application, separation is effectively by molecular weight. Reproduced by permission of Mayo Foundation for Medical Education and Research. All rights reserved.
Generally speaking, MALDI-TOF MS performs at least as well as, if not better than, automated biochemical identification for commonly encountered bacteria and yeast (Table 1) , and better for unusual organisms. We compared the BD Phoenix Automated Microbiology System and Biotyper system using 440 common and unusual gram-negative bacilli; the former correctly identified 83% and 75% of isolates to the genus and species levels, respectively, whereas MALDI-TOF MS correctly identified 93% and 82% of isolates to the genus and species levels, respectively [11] . We also evaluated the Biotyper system using 217 clinical isolates of staphylococci, streptococci, and enterococci, 98% and 79% of which were correctly identified to the genus and species levels, respectively [12] . The performance of the 2 commercial systems appears to be similar. Martiny et al reported 93% species-level identifications of 1003 routine bacterial isolates with both a prerelease version of the VITEK MS v1.1 database and the Biotyper system [6] .
In most cases, organisms are either correctly identified or yield a low score/percentage, indicating that identification has not been achieved; the latter typically implies no "match" in the database but can occur due to technically poor preparation. Misidentifications are unusual but may occur with some closely related organisms. Although a comprehensive review of identification of specific organisms is beyond the scope of this article, some generalizations can be made. Identification of staphylococci [13] and β-hemolytic streptococci is excellent [14] . The α-hemolytic streptococci are more problematic because Streptococcus mitis and Streptococcus oralis may be poorly differentiated from one another and from Streptococcus pneumoniae, at least with the Bruker system [12, 15] ; recent data suggest that VITEK MS may overcome this limitation [8] . Arcanobacterium haemolyticum, Rhodococcus equi, and all but select closely related Corynebacterium species are reliably identified [9, 16] .
Some closely related organisms, such as Escherichia coli and Shigella species, are not differentiated. (To avoid potential misidentification, we attempt to avoid testing of suspect E. coli and we perform additional testing if E. coli is suggested.) MALDI-TOF MS accurately detects Enterobacter cloacae complex, although it may not discriminate some species within this complex [9, 17] . Likewise, accurate differentiation of all species of Acinetobacter may be challenging with current databases, although Acinetobacter baumannii is identifiable [18] . Similar challenges exist with other identification systems. MALDI-TOF MS is exciting because of the breadth and depth of organism types that can be identified with one platform, including, but not limited to, Aeromonas species [19] , Campylobacter species, Arcobacter butzleri, and Yersinia enterocolitica [20] . MALDI-TOF MS can identify and differentiate Capnocytophaga canimorsus from Capnocytophaga cynodegmi [21] . Although typing within the genus Salmonella is not generally possible, it may be possible to distinguish Salmonella enterica subspecies enterica serovar Typhi from other S. enterica serovars [22] . And with user-supplemented databases, HACEK organisms [23] , Legionella species [24] , and Nocardia species [25] (the last with specific extraction procedures) may be identified.
Jamal et al reported species-level identification of 89% and 100% of 274 routinely isolated anaerobic bacteria (enriched in Bacteroides fragilis) using the Biotyper DB Update v3.3 and the VITEK MS v1 system/v1.1 database, respectively [10] . Identification of more esoteric anaerobes, including Prevotella species, has been successful in 83% of cases with user supplementation of Bruker's Reference Library 3.2.1.0 [26] . We evaluated a diverse collection of 253 clinical anaerobic isolates using the Biotyper system and a user-supplemented database; 92% and 71% of isolates were correctly identified to the genus and species levels, respectively [27] . Further commercial database supplementation will improve anaerobic identification to a level previously possible only with 16S ribosomal RNA gene sequencing or gas liquid chromatography. MALDI-TOF MS can accurately identify Francisella tularensis and Brucella species; however, the Biotyper library does not contain and will not identify these organisms. Use of Bruker's "Security Relevant" database enables Brucella species and F. tularensis identification [28] .
A handful of investigators have reported using MALDI-TOF MS for mycobacteria. This requires special processing to kill tested organisms (for safety), disrupt clumped cells, and break down cell envelopes. Current commercial libraries inadequately address the clinically relevant Mycobacterium species, but with appropriate library construction, MALDI-TOF MS should be able to identify most, with a few caveats expected. Members of the Mycobacterium tuberculosis complex are identified at the complex level [29] ; some species (eg, Mycobacterium abscessus/ massiliense; Mycobacterium mucogenicum/phocaicum; Mycobacterium chimaera/intracellulare) may not be well differentiated from one another [29] , and identification from liquid media may be more challenging than from colonies on solid media [30] .
Beyond bacteria, MALDI-TOF MS can identify yeast, outperforming some conventional phenotypic systems, and distinguishing Candida dubliniensis and albicans; Candida rugosa and pararugosa; Candida norvegensis, krusei, and inconspicua; Candida parapsilosis, orthopsilosis, and metapsilosis [31] ; and (with database supplementation) Cryptococcus neoformans and gattii [32] [33] [34] . Dhiman et al evaluated the Biotyper system for identification of 138 common and 103 unusual yeast isolates, and reported 96% and 85% accurate species-level identification, respectively [35] . MALDI-TOF MS may outperform current systems to identify esoteric and sometimes misidentified Candida species, such as Candida famata [31] . Although older studies used preparatory extraction for yeasts, we and others use the same direct testing strategy we use for bacteria (Figure 1) [36, 37] .
Few filamentous fungi are included in current commercial databases. Filamentous fungi exhibit variable phenotypes; protein spectra may vary with growth conditions or with the zone of fungal mycelium analyzed. De Carolis et al developed a library of Aspergillus species, Fusarium species, and Mucorales using the Biotyper system and identified 97% of 94 isolates to the species level [38] . Using the VITEK MS v1 system/v1.1 database and direct on-plate testing, Iriart et al identified 82% of 44 Aspergillus isolates (including all isolates with species in the database) [7] . Theel et al developed a dermatophyte library and used it to identify 93% and 60% of 171 dermatophyte isolates to the genus and species levels, respectively, using the Biotyper system [39] . Preliminary studies indicate that Pseudallescheria/ Scedosporium complex species are identifiable [40] . Beyond fungi, MALDI-TOF MS has been used for Prototheca species identification [41] .
Compared to standard methods, MALDI-TOF MS improves turn-around time for bacterial and fungal identification by an average of 1.45 days [42] , and, because only a small amount of organism is required, testing can be performed directly from single colonies on primary culture plates, whereas other methods may require subculture. Tests for screening for some enteric pathogens (eg, triple sugar iron agar for Salmonella species) may be eliminated [43] .
MALDI-TOF MS reagent costs are approximately $0.35/test; implementation reduces reagent and labor costs for identification, in one model, by 57% within 1 year [42] . An estimated 87% of isolates are identified on the first day (compared with 9% with standard techniques), with final identifications a day earlier for most organisms, and several days earlier for biochemically inert, fastidious, or slow-growing organisms [42] . DNA sequencing expenses are avoided for some esoteric organisms, waste disposal is decreased, and quality control and laboratory technologist training/labor for replaced/retired tests are eliminated [44] .
Adoption of MALDI-TOF MS impacts laboratory workflow [9] . Time at the bench assessing primary cultures is relatively unaffected, with subcultures needed for susceptibility testing. Gram staining of colonies may not always be needed, as this information is not required for MALDI-TOF MS. For some organisms (eg, S. aureus), rapid tests performed at the bench will remain.
MALDI-TOF MS has limitations (Table 2) . Unlike publically available sequence databases such as GenBank, MALDI-TOF MS databases are proprietary. Although low identification percentages for some organisms may be improved by user addition of mass spectral entries of underrepresented species or strains (to cover intraspecies variability) to the database, or even readdition of reference strain spectra [26] , doing so may be beyond the capabilities of some laboratories. Because of low scores/percentages, repeat testing is required for approximately 10% of isolates [42] . Growth on some media (eg, colistin-nalidixic acid agar) may be associated with low scores/percentages [45] , and tiny or mucoid colonies may fail identification [9, 46] . Refined criteria are needed to distinguish closely related species and to differentiate them from the next best taxon match [47] . For certain species of organisms, genus-or species-specific (including lowered) cutoffs may be appropriate [13, 16, 48] . Laboratory errors may occur, including colony inoculation in erroneous target plate locations, testing impure colonies, smearing between spots, failure to clean target plates, and erroneous result entry into laboratory information systems. There is a learning curve to applying ideal colony amounts to target plates [9] . Instrument cost is comparable to that of other common laboratory equipment; laser, software, hardware, or mass spectrometer failure require an appropriate service plan. Although MALDI-TOF MS is generally reproducible, sources of variability include the mass spectrometer, matrix and solvent composition, technologists, culture conditions, and biological variability; quality control strategies are being defined. Notably, MALDI-TOF MS may yield different (generally more accurate) identification than current systems [11, 49] .
Antimicrobial susceptibility is not directly determined with the above-described strategy. By rapid organism identification, intrinsic antimicrobial resistance characteristics of particular species (or typical susceptibility of the identified species based on local antibiograms) may guide therapy. Some investigators have incubated bacteria with antibiotics and measured antibiotic degradation using MALDI-TOF MS; this requires specific system configuration and incubation (ie, to allow antibiotic hydrolysis) and applies only to resistance mechanisms associated with antibiotic degradation (eg, β-lactamases) [50] . Although detection of methicillin resistance in S. aureus has been controversial, this does not appear to be feasible using the Biotyper software in detection ranges and instrument settings preset for microbial identification [51] . Microbial strain typing is under development with no current "universal protocol"; innovations and advances are expected. With strain typing [52, 53] , strains of S. aureus likely to be methicillin resistant (eg, USA300 [54] ), enterococci likely to be vancomycin resistant [55] , or Bacteroides fragilis likely to be carbapenem resistant (cfiA positive) [56] may be called out (as markers for possible resistance).
Although direct testing of clinical specimens is not generally feasible because of a high limit of detection, urine may be tested directly due to the high numbers of bacteria present in clinically infected urine (although α-defensins 1, 2, and 3 may impair database matching [57] ).
Rapid identification of microorganisms growing in blood culture bottles is promising, but requires preparatory specimen processing as blood culture bottles contain macromolecules from blood and growth media. Processing is accomplished with differential centrifugation and washings, selective lysis of blood cells (eg, using water, ammonium chloride, saponin, sodium dodecyl sulfate), separator gels, filtration, and so on; commercial blood culture bottle processing using the Sepsityper (Bruker Daltonics) is available [58] [59] [60] [61] [62] [63] [64] . Although results are valid when obtained, the yield is generally not as good as direct colony testing with a higher percentage of gram-negative than gram-positive organisms being identified [58] ; polymicrobial cultures may not be fully characterized (although strategies are being developed). Most Candida species are identifiable [65] . An alternate approach is to subculture positive blood culture bottles to solid media and test growth after a short period (eg, 2-4 hours) of incubation [66, 67] . By testing of positive blood culture bottles using MALDI-TOF MS, the time to organism identification may be reduced by a day or more, which may serve as a guide for empirical treatment [68] , but antimicrobial susceptibility is not provided. Recently, MALDI-TOF MS has been tied with direct antimicrobial susceptibility testing from positive blood culture bottles [69, 70] , improving time to optimal therapy and decreasing hospital length of stay and costs [71] .
In summary, MALDI-TOF MS is a quantum leap forward for rapid and accurate identification of cultured bacteria and fungi in clinical microbiology. This is incontrovertibly beneficial to laboratories, and decreased expense is helpful to laboratories and patients alike. MALDI-TOF MS implementation may impact patient outcomes and/or cost of care, depending on its application. Further, this new technology may provide better definition of the epidemiology, pathogenesis, and antimicrobial susceptibility of hitherto unrecognized (or misidentified) microorganisms.
Notes
Acknowledgments. I thank Dr Nancy L. Wengenack, Scott A. Cunningham, Brenda L. Dylla, and Sherry M. Ihde for their thoughtful reviews of this manuscript.
Potential conflicts of interest. Author certifies no potential conflicts of interest.
The author has submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. Growth on some media associated with no identification (without extraction)
Tiny or mucoid colonies may not be identified
